Tarsus Pharmaceuticals Inc share price logo

Tarsus Pharmaceuticals Inc Share Price

NASDAQ: TARS

Mid Cap

$64.19

-0.32

(-0.50%)

as on

Tarsus Pharmaceuticals Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $63.54
    $67.31
    downward going graph

    1.01%

    Downside

    4.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $38.51
    $85.25
    downward going graph

    40.01%

    Downside

    32.81%

    Upside

    downward going graph

Tarsus Pharmaceuticals Inc share price movements today

Previous Close
$64.51
Open
$66.25
Volume
597.3K
Day's Low - High
$63.54 - $67.31
52 Week Low - High
$38.51 - $85.25

Tarsus Pharmaceuticals Inc Historical Returns

1 Month Return
-7.3 %
3 Month Return
-21.45 %
1 Year Return
+ 29.1 %
3 Year Return
+ 431.38 %
5 Year Return
+ 113.33 %

Tarsus Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Tarsus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-0.8433

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

-69.2M

Revenue (TTM)

451.4M

Profit Margin

-14.72%

Return On Equity TTM

-23.39%

Tarsus Pharmaceuticals Inc Stock Valuation

Track how Tarsus Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Tarsus Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-46.09x)

December 31, 2025

Today (-7.00x)

March 23, 2026

Industry (-4.74x)

March 23, 2026

Highest (-3.60x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -7.00x

Tarsus Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tarsus Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tarsus Pharmaceuticals Inc image
Tarsus Pharmaceuticals Inc
BUY$2.7B113.33%-7-14.72%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Tarsus Pharmaceuticals Inc Stock including INR - Dollar returns

The Tarsus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tarsus Pharmaceuticals Inc investment value today

Current value as on today

₹1,37,998

Returns

₹37,998

(+38%)

Returns from Tarsus Pharmaceuticals Inc Stock

₹28,457 (+28.46%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Tarsus Pharmaceuticals Inc Stock

Based on 15 analysts

BUY

86.67%

Buy

13.33%

Hold

0.00%

Sell

Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Tarsus Pharmaceuticals Inc. Average target price of $94.44

Tarsus Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Tarsus Pharmaceuticals Inc.

What analysts predicted

32.03%UPSIDE

Target Price

$94.44

Current Price

$64.19

Analyzed by

15 Analysts

Target

$94.44

Tarsus Pharmaceuticals Inc target price $94.44, a slight upside of 32.03% compared to current price of $64.19. According to 15 analysts rating.

Tarsus Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Tarsus Pharmaceuticals Inc Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:67% versus previous 30 day period

Tarsus Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1
13
27
40
48
66
78
102
118
151
Gross Profit
1
11
25
37
44
61
73
96
94
140
Operating Income
-40
-44
-37
-33
-25
-24
-26
-22
-14
-7
EBITDA
-38
-40
-34
-30
-20
-20
-22
-17
-12
-3
Interest Expense
0
0
0
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-39
-41
-35
-33
-23
-23
-25
-20
-12
-6
Income Tax Expense
-1
30
0
-
-
-
-
-
-
2
Net Income
-39
-41
-35
-33
-23
-23
-25
-20
-12
-8
Net Profit Margin
-2092.36%
-320.45%
-129.39%
-81.57%
-48.67%
-34.80%
-32.07%
-19.81%
-10.60%
-5.52%

Tarsus Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
33
57
25
17
182
451
Gross Profit
0
0
0
54
24
15
170
420
Operating Income
-1
-4
-26
-12
-62
-143
-120
-70
EBITDA
-1
-4
-26
-13
-59
-131
-106
-53
Interest Expense
-
0
0
2
2
3
7
8
Depreciation
0
0
0
0
0
0
1
1
Income Before Tax
-1
-4
-26
-13
-62
-135
-115
-64
Income Tax Expense
0
0
0
0
0
0
-
2
Net Income
-1
-4
-26
-13
-62
-135
-115
-66
Net Profit Margin
0.00%
0.00%
-80.20%
-24.25%
-240.51%
-778.89%
-63.16%
-14.72%

Tarsus Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-41
-35
-33
-23
-23
-25
-20
-12
-8
Operating Cash Flow
-39
-37
-14
-8
-22
-20
-29
18
19
Investing Cash Flow
17
-102
-40
3
-59
-34
-51
-4
49
Financing Cash Flow
19
108
42
0
2
136
1
2
2
Change in Cash
-1
-31
-12
-4
-78
80
-79
16
70

Tarsus Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-26
-13
-62
-135
-115
-66
Operating Cash Flow
-3
-21
3
-49
-117
-83
-12
Investing Cash Flow
0
0
0
-144
140
-199
-42
Financing Cash Flow
59
131
0
93
130
154
143
Change in Cash
55
110
3
-99
153
-127
88

Global Institutional Holdings in Tarsus Pharmaceuticals Inc

Funds
Holdings
Bank of America Corp
1.26%
Assenagon Asset Management SA
2.65%
Amvescap Plc.
2.2%
State Street Corp
2.2%
Lord, Abbett & Co LLC
2.01%
See all

Insights on Tarsus Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, TARS stock has moved up by 438.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TARS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TARS has outperformed top 5 stocks with highest market-cap in its industry

About Tarsus Pharmaceuticals Inc

tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. its lead product candidate is tp-03, a novel therapeutic that is in phase iib/iii for the treatment of blepharitis caused by the infestation of demodex mites, as well as to treat meibomian gland disease. the company is also developing tp-04 for the treatment of rosacea; and tp-05 for lyme prophylaxis and community malaria reduction. tarsus pharmaceuticals, inc. was founded in 2016 and is headquartered in irvine, california.
OrganisationTarsus Pharmaceuticals Inc
Headquarters15440 Laguna Canyon Road, Irvine, CA, United States, 92618
IndustryHealth Technology
CEODr. Bobak R. Azamian M.D.
E-voting on sharesClick here to vote

Key Management of Tarsus Pharmaceuticals Inc

Name

Title

Dr. Bobak R. Azamian M.D.

Co-Founder, President, CEO & Chairman

Dr. Seshadri Neervannan Ph.D.

Chief Operating Officer

Dr. Bryan Wahl J.D., M.D.

General Counsel & Corporate Secretary

Ms. Adrienne Kemp

Senior Director of Corporate Communications

Mr. Matthew Rossen M.B.A.

Vice President of Marketing

Mr. Jeffrey S. Farrow CPA

CFO & Chief Strategy Officer

Mr. Aziz Mottiwala M.B.A.

Chief Commercial Officer

Dr. Elizabeth Yeu M.D.

Chief Medical Officer

Mr. David Nakasone

Head of Investor Relations

Mr. Scott Youmans

Vice President of Sales

FAQs

What is Tarsus Pharmaceuticals Inc share price today?

Tarsus Pharmaceuticals Inc share price today is $64.19 as on at the close of the market. Tarsus Pharmaceuticals Inc share today touched a day high of $67.31 and a low of $63.54.

What is the 52 week high and 52 week low for Tarsus Pharmaceuticals Inc share?

Tarsus Pharmaceuticals Inc share touched a 52 week high of $85.25 on and a 52 week low of $38.51 on . Tarsus Pharmaceuticals Inc stock price today i.e. is closed at $64.19,which is 24.70% down from its 52 week high and 66.68% up from its 52 week low.

What is Tarsus Pharmaceuticals Inc's market capitalisation today?

Tarsus Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Tarsus Pharmaceuticals Inc Stock (TARS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tarsus Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tarsus Pharmaceuticals Inc Shares that will get you 0.0234 shares as per Tarsus Pharmaceuticals Inc share price of $64.19 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tarsus Pharmaceuticals Inc Stock (TARS) from India?

Indian investors can start investing in Tarsus Pharmaceuticals Inc (TARS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Tarsus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Tarsus Pharmaceuticals Inc share’s latest price of $64.19 as on March 24, 2026 at 1:29 am IST, you will get 0.1558 shares of Tarsus Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Tarsus Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Tarsus Pharmaceuticals Inc stock has given 113.33% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?